These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 9597127)

  • 1. Regulation of immune responses by TGF-beta.
    Letterio JJ; Roberts AB
    Annu Rev Immunol; 1998; 16():137-61. PubMed ID: 9597127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transforming growth factor beta-1: structure, function, and regulation mechanisms in cancer].
    Peralta-Zaragoza O; Lagunas-Martínez A; Madrid-Marina V
    Salud Publica Mex; 2001; 43(4):340-51. PubMed ID: 11547595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells, transforming growth factor-beta, and immune suppression.
    Wan YY; Flavell RA
    Proc Am Thorac Soc; 2007 Jul; 4(3):271-6. PubMed ID: 17607012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta: an important mediator of immunoregulation.
    Kehrl JH
    Int J Cell Cloning; 1991 Sep; 9(5):438-50. PubMed ID: 1955735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta (TGF-beta) and autoimmunity.
    Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor beta in the pathophysiology of chronic inflammation.
    Wahl SM; Costa GL; Mizel DE; Allen JB; Skaleric U; Mangan DF
    J Periodontol; 1993 May; 64(5 Suppl):450-5. PubMed ID: 8315567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta and the immune system.
    Ruscetti FW; Palladino MA
    Prog Growth Factor Res; 1991; 3(2):159-75. PubMed ID: 1663407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta regulation of immune responses.
    Li MO; Wan YY; Sanjabi S; Robertson AK; Flavell RA
    Annu Rev Immunol; 2006; 24():99-146. PubMed ID: 16551245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic consequences of transforming growth factor beta1 gene ablation in murine embryonic fibroblasts: autocrine control of cell proliferation and extracellular matrix biosynthesis.
    Sudarshan C; Yaswen L; Kulkarni A; Raghow R
    J Cell Physiol; 1998 Jul; 176(1):67-75. PubMed ID: 9618146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
    Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
    Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.